Search

Displaying results 5961 - 5970 of 10000 in total
  1. Drug

    Alvocidib

    go.drugbank.com/drugs/DB03496
    Investigational

    Alvocidib is a synthetic flavonoid based on an extract from an Indian plant for the potential treatment of cancer. … It works by inhibiting cyclin-dependent kinases, arresting cell division and causing apoptosis in non-small lung cancer cells.

  2. Drug

    Methallenestril

    go.drugbank.com/drugs/DB13143
    Experimental

    Categories: Sex Hormones and Modulators of the Genital System
  3. Drug

    Methylestrenolone

    go.drugbank.com/drugs/DB13533
    Investigational

    Categories: Sex Hormones and Modulators of the Genital System
  4. Drug

    4-hydroxybenzoyl-CoA

    go.drugbank.com/drugs/DB01652
    Experimental

    Categories: Thioesters of coenzyme A
  5. Drug

    3-Hydroxybutyryl-Coenzyme A

    go.drugbank.com/drugs/DB03612
    Experimental

    Categories: Thioesters of coenzyme A
  6. Drug

    Succinyl-Coenzyme A

    go.drugbank.com/drugs/DB03699
    Experimental

    Categories: Thioesters of coenzyme A
  7. Drug

    Octanoyl-Coenzyme A

    go.drugbank.com/drugs/DB02910
    Experimental

    Categories: Thioesters of coenzyme A
  8. Drug

    Tanogitran

    go.drugbank.com/drugs/DB21367
    Investigational

    Tanogitran has a monoisotopic molecular weight of 477.25 Da. … Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects).

  9. Drug

    Lucanthone

    go.drugbank.com/drugs/DB04967
    Investigational

    One of the schistosomicides, it has been replaced largely by hycanthone and more recently praziquantel. (From Martindale The Extrapharmacopoeia, 30th ed., p46).

    Synonyms: 1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one, 1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-oneInternational brands: Miracil D
  10. Drug

    Dirucotide

    go.drugbank.com/drugs/DB04921
    Investigational

    Dirucotide has been developed for the treatment of multiple sclerosis (MS). Developed at the University of Alberta, dirucotide is being investigated by BioMS Medical Corp. … In particular, the sequence prepared is a 17 amino acid chain that is identical to a section of myelin basic protein (MBP) that is found in humans.